Skip to content
To the full analysis

Mesa Laboratories stock: balance sheet and debt

MLAB
$135.20Closing price of 12 Nov 2026MEQIRI Score 58 out of 100

Mesa Laboratories has a debt to equity ratio of 0.91 and an interest coverage of 2.1x.

Daily figure as of 13 Nov 2026

Debt / Equity
0.91
Interest coverage
2.1x
Current ratio
1.72
Cash & equivalents
$26.93M
Total assets
$427.75M
Equity ratio
43.5%
Goodwill
$186.86M
Plus intangible assets of $83.35M
Net debt
$141.9M

Total assets and equity ratio

How large the balance sheet of Mesa Laboratories, Inc. is, how much of it is equity and how much is goodwill from acquisitions.

Equity ratio

Figures as a table
YearTotal assetsGoodwill and intangible assetsof which goodwillEquity ratioNet debt
2007$22.35M$7.99M$5.3M92.7%−$3.35M
2008$25.53M$7.49M$5.3M93.0%−$5.77M
2009$29.61M$6.99M$5.3M93.2%−$9.11M
2010$33.64M$8.93M$6.27M92.7%−$10.47M
2011$50.98M$25.93M$14.45M71.4%$2.95M
2012$50.7M$24.27M$14.45M86.6%−$7.19M
2013$65.92M$39.06M$23.64M80.0%−$6K
2014$97.53M$63.28M$37.87M66.0%$10.93M
2015$117.32M$78.1M$44.87M62.6%$24.22M
2016$160.75M$106.93M$66.14M52.7%$39.56M
2017$171.73M$109.95M$72.16M57.0%$48.98M
2018$164.1M$108.39M$65.54M60.5%$40.79M
2019$156.77M$99.6M$66.38M71.0%$12.55M
2020$420.21M$261.41M$141.54M52.4%$59.99M
2021$601.48M$272.58M$160.84M67.5%−$117.17M
2022$707.37M$541.28M$291.17M55.7%$171.79M
2023$661.83M$503.26M$286.44M59.5%$153.23M
2024$446.8M$293.85M$180.1M32.5%$203.08M
2025$433.35M$278.64M$181.76M36.9%$154.15M
2026$427.75M$270.21M$186.86M43.5%$141.9M

The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt.

Equity and debt

What the company owns and owes

  • Cash & equivalents
  • Equity
  • Debt
Figures as a table
YearCash & equivalentsEquityDebtDebt / Equity
2007$3.35M$20.72M$00
2008$5.77M$23.74M$00
2009$9.11M$27.6M$00
2010$10.47M$31.2M$00
2011$3.55M$36.42M$6.5M0.18
2012$7.19M$43.92M$00
2013$4.01M$52.75M$4M0.08
2014$5.58M$64.33M$16.5M0.26
2015$2.03M$73.48M$26.25M0.36
2016$5.7M$84.68M$45.25M0.53
2017$5.82M$97.82M$54.8M0.56
2018$5.47M$99.36M$46.26M0.47
2019$10.19M$111.31M$22.74M0.2
2020$81.38M$220.01M$141.37M0.64
2021$263.87M$406.23M$146.7M0.36
2022$49.35M$393.8M$221.13M0.56
2023$32.91M$393.48M$186.14M0.47
2024$28.21M$145.39M$231.3M1.59
2025$27.32M$159.83M$181.47M1.14
2026$26.93M$186.25M$168.83M0.91

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2026, period end 31 Mar 2026
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 3 Apr 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy